INTERNATIONAL PATENT: PROGENEER INC., 프로지니어 주식회사 FILES APPLICATION FOR "COMBINATION THERAPY OF ANTICANCER TREATMENT WITH TOLL-LIKE RECEPTOR 7 OR 8 AGONIST HAVING ACTIVE SITE TEMPORARILY INACTIVATED FOR CANCER TREATMENT"

GENEVA, June 3 -- PROGENEER INC. (1002-ho, 10F, 12 Digital-ro 31-gil,Guro-gu,Seoul 08380), 프로지니어 주식회사 (서울특별시구로구디지털로31길 12,10층 1002호) filed a patent application (PCT/KR2024/018697) for "COMBINATION THERAPY OF ANTICANCER TREATMENT WITH TOLL-LIKE RECEPTOR 7 OR 8 AGONIST HAVING ACTIVE SITE TEMPORARILY INACTIVATED FOR CANCER TREATMENT" on Nov 22, 2024. With publication no. WO/2025/110816, the details related to the patent application was published on May 30, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is ma...